# Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)

> **NCT02722148** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 24 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DEVICE:** Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy

## Key facts

- **NCT ID:** NCT02722148
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-21
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02722148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02722148, "Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02722148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*